GILD vs MRK

Gilead Sciences against Merck & Co. — live side-by-side technical comparison.

Prices as of 2026-10-16T20:00:02+00:00 UTC · updates daily

Who leads right now

MRK leads 3 of the 5 windows we measure — over 1 month GILD is +5.8% and MRK +0.7%; over year to date GILD is +27.2% and MRK +38.7%. The GILD/MRK price ratio stands at 1.0702, above its 50-day average of 1.0125, and below the 200-day average of 1.1127. A ratio above its own average means GILD is gaining on MRK; on this reading the recent edge belongs to GILD.

Performance side by side

GILDMRK
Price$156.19 $145.95
1 day -0.8% +0.5%lead
5 days +3.3%lead +0.2%
1 month +5.8%lead +0.7%
6 months +12.7% +26.4%lead
Year to date +27.2% +38.7%lead
52-week position 91% of range 85% of range
52-week range $114.02–$160.51 $82.01–$156.92
vs 50-day average above $146.84 above $145.12
vs 200-day average above $138.03 above $124.87
RSI (14) 57 45
Next earnings 2026-10-292026-10-29

Where each one stands

GILD — Gilead Sciences

GILD trades at $156.19, above its 50-day average of $146.84, and above the 200-day at $138.03. It sits at 91% of its 52-week range ($114.02–$160.51); 14-day RSI is 57, in neutral territory; an average session moves it about 2.4%. For levels, the first level overhead is $157.37 (0.8% away) and the first support below is $153.38 (1.8% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.

MRK — Merck & Co.

MRK trades at $145.95, above its 50-day average of $145.12, and above the 200-day at $124.87. It sits at 85% of its 52-week range ($82.01–$156.92); 14-day RSI is 45, in neutral territory; an average session moves it about 2.7%. For levels, the first level overhead is $150.00 (2.8% away) and the first support below is $145.12 (0.6% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.

Which one moves harder

MRK is the more volatile of the two — an average session moves it 2.7% against 2.4% for GILD, so an identical position size carries roughly 1.1× the daily risk.

What would change the picture

The comparison turns on those levels: GILD clearing $157.37 or losing $153.38; MRK clearing $150.00 or losing $145.12. Until one of them gives way, the relative reading above stands.

Questions people ask about GILD vs MRK

Which is performing better right now, GILD or MRK?
Over the past month GILD is +5.8% and MRK is +0.7%, so GILD is ahead on that window. Year to date the figures are +27.2% for GILD and +38.7% for MRK.
Is GILD or MRK more volatile?
MRK is the more volatile of the two — an average session moves it 2.7% against 2.4% for GILD, so an identical position size carries roughly 1.1× the daily risk.
What are the key levels for GILD and MRK?
GILD: resistance $157.37, support $153.38; MRK: resistance $150.00, support $145.12. Levels come from recent swing zones and round numbers, recomputed daily.
When do GILD and MRK report next?
GILD: 2026-10-29. MRK: 2026-10-29. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.
What does the GILD/MRK ratio mean?
It is simply GILD's price divided by MRK's — 1.0702 today. When the ratio rises, GILD is outperforming; when it falls, MRK is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.

Full technical briefs

GILD →
Gilead Sciences
Full technical brief: trend, levels, chart, news
MRK →
Merck & Co.
Full technical brief: trend, levels, chart, news

Related comparisons

JNJ vs LLYABBV vs LLYLLY vs UNHLLY vs MRKLLY vs TMOAMGN vs LLYGILD vs LLYABT vs LLY